Researcher

Deyu Li

Department of Neurology, Jiangsu Province Hospital of Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province 210001, China.

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 28, 2026 · JOURNAL ARTICLE

Genomic surveillance reveals escalating antimicrobial resistance and plasmid diversity in clinical Salmonella 1,4,[5],12:i:- ST34 isolates from Guizhou Province, China

Frontiers in Microbiology

A 5-year genomic surveillance study of a single Salmonella serotype in one Chinese province, providing descriptive epidemiology and resistance patterns without a control group or clinical outcomes, useful for understanding local resistance trends but not sufficient to guide practice changes.

PreliminaryGe Zhu Deyu Li Junhua Wang

Reported

Ciprofloxacin resistance22.4%

Azithromycin resistance11.4%

Ceftazidime resistance18.5%

JUN 26, 2026 · JOURNAL ARTICLE

Neuroinflammation-centered pathophysiology and therapeutic strategy design in Alzheimer's disease: Cutting-edge developments.

Cellular Signalling

A narrative review synthesizing current understanding of AD pathogenesis and therapeutic strategies; positions neuroinflammation as central and identifies actionable immune targets, but provides no new empirical data or comparative efficacy evidence.

Expert GuidanceZhezuo Zhang Neuroinflammatory Diseases Wenhui Cai